News
ONVO
--
0.00%
--
Organovo Granted EU Patent "ENGINEERED THREE-DIMENSIONAL SKIN TISSUES, ARRAYS THEREOF, AND METHODS OF MAKING THE SAME'
https://data.epo.org/publication-server/pdf-document?pn=3215603&ki=B1&cc=EP
Benzinga · 1d ago
3D Printing Medical Device Market- Strategic Plans by Globally Industry Demand, On Going Trends, Regional Overview, Business Growth and Forecast to 2026
Research Nester has released a report titled which also includes some of the prominent market analyzing parameters such as industry growth drivers, restraints, supply and demand risk, market attractiveness, year-on-year (Y-O-Y) growth comparisons, market s...
AmericaNewsHour · 09/14 08:19
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers
Benzinga · 08/31 13:32
58 Biggest Movers From Friday
Gainers Regencell Bioscience Holdings Limited (NASDAQ: RGC) shares climbed 204.1% to close at $19.16 on Friday. Regencell Bioscience reported partial exercise of underwriter’s over-allotment option.
Benzinga · 08/23 09:06
ONVO, JOBY and PXLW among mid-day movers
Gainers: Greenpro Capital (NASDAQ:GRNQ) +61%. GeoVax Labs (NASDAQ:GOVX) +49%. Flora Growth Corp. (NASDAQ:FLGC) +31%. Pixelworks (NASDAQ:PXLW) +20%. XTL Biopharmaceuticals (NASDAQ:XTLB) +18%. Leju Holdings (NYSE:LEJU) +17%. Zhihu (NYSE:ZH) +17%. Organovo (N...
Seekingalpha · 08/20 16:34
GeoVax Labs, Flora Growth leads healthcare gainers; Progenity, Sonnet BioTherapeutics among major losers
Gainers: GeoVax Labs (NASDAQ:GOVX) +52%, Flora Growth (NASDAQ:FLGC) +30%, XTL Biopharmaceuticals (NASDAQ:XTLB) +17%, Organovo (NASDAQ:ONVO) +16%, Impel NeuroPharma (NASDAQ:IMPL) +11%. Losers: Progenity (NASDAQ:PROG) -55%, Sonnet BioTherapeutics (NASDAQ:SON...
Seekingalpha · 08/20 15:04
/C O R R E C T I O N from Source -- RBC Global Asset Management Inc./
RBC Global Asset Management Inc. ("RBC GAM Inc.") today announced June 2021 cash distributions for unitholders of RBC ETFs, as follows:
CNW Group · 06/22 14:17
Is Organovo Holdings Inc (ONVO) A Good Stock To Buy?
While the market driven by short-term sentiment influenced by the accommodative interest rate environment in the US, virus news and stimulus spending, many smart money investors are starting to get cautious towards the current bull run since March, 2020 an...
Insider Monkey · 06/15 15:38
Asensus Surgical to join Russell Microcap Index, while Sorrento Therapeutics to see deletion
At the conclusion of the 2021 Russell indexes annual reconstitution, following notable healthcare stocks will join the Russell Microcap Index, effective June 28 after the U.S. market opens.Asensus Surgical (ASXC), Organovo
Seekingalpha · 06/14 19:29
Organovo Holdings Granted European Patent Titled 'AUTOMATED DEVICES, SYSTEMS, AND METHODS FOR THE FABRICATION OF TISSUE'
https://register.epo.org/application?number=EP14832338
Benzinga · 06/01 19:13
44 Biggest Movers From Friday
Gainers
Benzinga · 06/01 09:21
ONVO, YEXT, CTRM and SLCA among midday movers
Gainers: SemiLEDs (LEDS) +49%.Vertex Energy (VTNR) +45%.Organovo (ONVO) +28%.eMagin (EMAN) +24%.Mannatech (MTEX) +21%.Welbilt (WBT) +21%.Yext (YEXT) +19%.MoSys (MOSY) +16%.Embotelladora Andina (AKO-B) +13%.Iterum Therapeutics (ITRM) +17%.Losers: 1847 Goede...
Seekingalpha · 05/28 16:39
12 Health Care Stocks Moving In Friday's Intraday Session
 
Benzinga · 05/28 16:32
Organovo up 36% on bullish assessment of 3D human tissue biotech
Organovo Holdings (ONVO) has rocketed 36% to $9.80 in afternoon trading after Seeking Alpha contributor Gunner Laine Hardy offered a bullish assessment behind the 3D human tissue biotech.While Hardy cautions the stock
Seekingalpha · 05/28 16:11
Organovo, Iterum Therapeutics leads healthcare gainers; Provention Bio, Eton Pharmaceuticals among major losers
Gainers: Organovo (ONVO) +24%, Iterum Therapeutics (ITRM) +16%, Adagene (ADAG) +14%, Freeline Therapeutics (FRLN) +12%, 180 Life Sciences (ATNF) +12%.Losers: Provention Bio (PRVB) -22%, Eton Pharmaceuticals (ETON) -13%, Lannett (LCI) -12%, Regional Health ...
Seekingalpha · 05/28 15:03
Mid-Morning Market Update: Markets Open Higher; Big Lots Posts Upbeat Q1 Profit
Following the market opening Friday, the Dow traded up 0.24% to 34,547.73 while the NASDAQ rose 0.44% to 13,796.49. The S&P also rose, gaining 0.21% to 4,209.59.
Benzinga · 05/28 14:21
Organovo Shares Up 26%; Recent Seeking Alpha Article 'Organovo: New Strategy Targeting Internal Pipeline Development With Customized 3D Human Tissues Offers Upside'
https://seekingalpha.com/article/4431909-organovo-new-strategy-targetting-internal-pipeline-development-offers-upside
Benzinga · 05/28 14:12
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Benzinga · 05/21 12:13
Cathie Wood's Ark Loads Up Further On Tesla And Cuts Apple Stake
Cathie Wood-led Ark Investment Management on Tuesday snapped up $27.2 million worth of shares in Tesla Inc (NASDAQ: TSLA) after a two-week gap during which shares of the electric vehicle company have retreated about 15%.
Benzinga · 05/19 04:32
Cathie Wood Cuts Apple Stake Almost Entirely — And Buys More Coinbase
Cathie Wood-led Ark Investment Management on Monday shed nearly all of its stake in Apple Inc (NASDAQ: AAPL) and continued to snap up shares of Coinbase Global Inc (NASDAQ: COIN).
Benzinga · 05/18 05:20
Webull provides a variety of real-time ONVO stock news. You can receive the latest news about Organovo Holdings through multiple platforms. This information may help you make smarter investment decisions.
About ONVO
Organovo Holdings, Inc. is an early stage biotechnology company. The Company is focused on building high fidelity, three-dimensional (3D) tissues that recapitulate key aspects of human disease. The Company is targeting the intestine and has ongoing 3D tissue developments in Ulcerative colitis (UC) and Crohn's disease (CD). The Company uses its platform technology to build functional 3D human tissues that mimic key aspects of native human tissue composition, architecture, function and disease. Its NovoGen Bioprinters are automated devices that enable the fabrication of 3D living tissues comprised of mammalian cells. NovoGen Bioprinters can dispense pure hydrogel formulations and also serve as important components of company's tissue prototyping and manufacturing platform. The Company also intends to use its bioprinting platform as well as 3D technologies to treat its target diseases.